![]() | - SMTL ID
- 8tvm.1
- Ligands
- N-{1-[(1R,2R)-2-fluorocyclopropyl]-2-oxo-1,2-dihydropyridin-3-yl}-2-[(1R,4r)-1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl]-6-[(propan-2-yl)oxy]-2H-pyrazolo[3,4-b]pyridine-5-carboxamide
- Polypeptides
- Interleukin-1 receptor-associated kinase 4
- Oligo-state
- monomer
|
![]() | - SMTL ID
- 8tvm.2
- Ligands
- N-{1-[(1R,2R)-2-fluorocyclopropyl]-2-oxo-1,2-dihydropyridin-3-yl}-2-[(1R,4r)-1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl]-6-[(propan-2-yl)oxy]-2H-pyrazolo[3,4-b]pyridine-5-carboxamide
- Polypeptides
- Interleukin-1 receptor-associated kinase 4
- Oligo-state
- monomer
|
![]() | - SMTL ID
- 8tvm.3
- Ligands
- N-{1-[(1R,2R)-2-fluorocyclopropyl]-2-oxo-1,2-dihydropyridin-3-yl}-2-[(1R,4r)-1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl]-6-[(propan-2-yl)oxy]-2H-pyrazolo[3,4-b]pyridine-5-carboxamide
- Polypeptides
- Interleukin-1 receptor-associated kinase 4
- Oligo-state
- monomer
|
![]() | - SMTL ID
- 8tvm.4
- Ligands
- N-{1-[(1R,2R)-2-fluorocyclopropyl]-2-oxo-1,2-dihydropyridin-3-yl}-2-[(1R,4r)-1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl]-6-[(propan-2-yl)oxy]-2H-pyrazolo[3,4-b]pyridine-5-carboxamide
- Polypeptides
- Interleukin-1 receptor-associated kinase 4
- Oligo-state
- monomer
|